Scarica l'app Stockscreener
84.32
3.09%
-2.69
Dopo l'orario di chiusura:
84.43
0.11
+0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
What to Know About This Fund’s $3 Million Blackstone Mortgage Trust Sale Amid Office Stress - The Motley Fool
Abbott Laboratories Hires PhronesisDC on Tax Policy - Legis1
Abbott Laboratories Is On Sale, Don't Overlook It - Seeking Alpha
Abbott Laboratories: Mispriced Growth Behind Near-Term Noise? - TradingView
Abbott Laboratories stock (US0028241000): Shares hit 52-week low amid sector weakness and valuation - AD HOC NEWS
Abbott ends six-session losing streak - MSN
Pay Less, Gain More: RMD, MDT Top Abbott Laboratories Stock - Trefis
Abbott Laboratories Stock (ABT) Closed Down by 3.22% on May 8: A Full Analysis - TradingKey
Abbott’s BurstDR Trial Targets Painful Diabetic Neuropathy: What Investors Should Watch - TipRanks
Abbott Laboratories stock hits 52-week low at $86.15 By Investing.com - Investing.com Canada
Abbott Laboratories stock hits 52-week low at $86.15 - Investing.com
Abbott's Medical Device Strategy Supports Long-Term Growth Outlook - Yahoo Finance
Abbott Laboratories Stock: Analyst Estimates & Ratings - Barchart.com
Abbott Laboratories (NYSE:ABT) Presents a Decent Value Opportunity After 21% Pullback - ChartMill
Pregnancy Detection Kits Market Analysis Report 2026 - GlobeNewswire Inc.
Medtronic or Abbott Laboratories: Which Stock Has More Upside? - Trefis
Between Medtronic and Abbott Laboratories, Which Stock Looks Set to Break Out? - Trefis
Immunoassay Market Competitive Analysis to 2031 | Abbott, - openPR.com
Is Abbott Laboratories (ABT) Now Offering Value After Recent Share Price Weakness? - Yahoo Finance
What Abbott Laboratories (ABT)'s New AI Cardiac Imaging, Trial Data and Share Plan Mean For Shareholders - simplywall.st
symbol__ Stock Quote Price and Forecast - CNN
Abbott ends six-session losing streak (ABT:NYSE) - Seeking Alpha
Abbott Cardiac Data Sheds Light On Heart Rhythm Pipeline And Earnings Story - Yahoo Finance
Abbott loses appeal of nearly $500 million infant formula verdict - Crain's Chicago Business
Assessing Abbott Laboratories (ABT) Valuation After Prolonged Share Price Weakness - simplywall.st
NEC Baby Formula Lawsuit & Settlement | May 2026 Update - Lawsuit Information Center
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Cuts Target Price to $109 - Moomoo
Abbott stock is trading at 52-week lows but insiders are gobbling up shares of this blue-chip dividend payer - MSN
Court upholds $495 million verdict against Abbott Laboratories in case over preterm infant formula - Chicago Tribune
Abbott Stock Is Trading at 52-Week Lows but Insiders Are Gobbling Up Shares of This Blue-Chip Dividend Payer - Barchart.com
Missouri appeals court upholds $495M ruling against Abbott in baby formula case - Seeking Alpha
Abbott stock tumbles below key moving averages as sellers dominate momentum: weekly outlook - Traders Union
Bioabsorbable Stents Industry Projected to Grow at 10.2% CAGR, - openPR.com
Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase - marketscreener.com
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Abbott Laboratories stock underperforms Monday when compared to competitors - MarketWatch
Selling pressure pushes Abbott Laboratories stock lower in today's trading - Traders Union
Abbott gets FDA nod, CE mark for AI-enabled imaging device - MedTech Dive
Abbott Laboratories: performance and outlook - Business Recorder
This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy? - The Globe and Mail
Horizon Investments LLC Sells 48,862 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Stock Offers Growth Potential and High Dividends - HarianBasis.co
Abbott Laboratories $ABT Stock Holdings Lowered by CENTRAL TRUST Co - MarketBeat
Abbott Laboratories Stock Analysis: 30% Decline, 2.8% Yield, and Growth ProspectsNews and Statistics - IndexBox
ABT: Abbott Laboratories Director Acquires 10,000 Shares Amid De - GuruFocus
AGNC, Lam, Abbott, BlackRock, Schlumberger: Insider Shockwave - TipRanks
Strs Ohio Decreases Stake in Abbott Laboratories $ABT - MarketBeat
PFA Pension Forsikringsaktieselskab Makes New Investment in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Q1 2026 Earnings: $2B CGM Quarter, 65% Upside Priced In - TIKR.com
1 Magnificent Dividend Stock Down 30% to Buy and Hold Forever - The Motley Fool
Abbott Laboratories: Attractive Dividend Investment Opportunity - Intellectia AI
Abbott Laboratories stock underperforms Friday when compared to competitors - MarketWatch
AI Models Split on Abbott Laboratories (ABT) as Fundamentals Clash With Technical and Valuation Concerns - TipRanks
Abbott Laboratories (ABT) Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 Software - Yahoo Finance
Abbott–Exact Sciences, BioMarin–Amicus among deals cleared in Japan in Q1 - MLex
How Investors Are Reacting To Abbott (ABT) Gaining FDA, CE Clearance For AI-Guided Ultreon 3.0 - Yahoo Finance
Abbott Laboratories stock hits 52-week low at $90.72 - Investing.com
Abbott Laboratories stock hits 52-week low at $90.72 By Investing.com - Investing.com Australia
FDA Reports Baby Formula Safety, Highlights Abbott (ABT) Among C - GuruFocus
Abbott Laboratories (FRA:ABL0) Stock Price, Trades & News - GuruFocus
Abbott Receives FDA Clearance, CE Mark for Ultreon 3.0 AI Imaging Platform - AIM Media House
2.98%
3.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):